Cargando…
Hepatocellular Carcinoma—How to Determine Therapeutic Options
Deciding on specific treatment strategies involves not only tumor stage, performance status, and severity of underlying liver disease, but additional factors such as biomarkers, organ availability, and radiographic tumor response to treatment. In this review, we present hepatocellular carcinoma (HCC...
Autor principal: | Mehta, Neil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049673/ https://www.ncbi.nlm.nih.gov/pubmed/32140653 http://dx.doi.org/10.1002/hep4.1481 |
Ejemplares similares
-
New Therapeutic Options for Advanced Hepatocellular
Carcinoma
por: Ma, Yu-Shui, et al.
Publicado: (2020) -
Overview of hepatocellular carcinoma: from molecular aspects to future therapeutic options
por: Panneerselvam, Sugan, et al.
Publicado: (2023) -
Determination of fitness and therapeutic options in older patients with acute myeloid leukemia
por: Cortes, Jorge E., et al.
Publicado: (2021) -
The Role of Cabozantinib as a Therapeutic Option for Hepatocellular Carcinoma: Current Landscape and Future Challenges
por: D’Alessio, Antonio, et al.
Publicado: (2021) -
Second-line treatment options in hepatocellular carcinoma
por: Marino, Donatella, et al.
Publicado: (2019)